Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
Xiang J, Lu M, Shi M, Cheng X, Kwakwa KA, Davis JL, Su X, Bakewell SJ, Zhang Y, Fontana F, Xu Y, Veis DJ, DiPersio JF, Ratner L, Sanderson RD, Noseda A, Mollah S, Li J, Weilbaecher KN.
Xiang J, et al. Among authors: li j.
J Virol. 2022 Apr 13;96(7):e0005722. doi: 10.1128/jvi.00057-22. Epub 2022 Mar 23.
J Virol. 2022.
PMID: 35319225
Free PMC article.